Fulminant sepsis after liver biopsy: A long forgotten complication?

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 1, Issue 1

This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

369

HTML

3267

Figures (1-2)

386

Tables (1-1)

368

Sum=4390

Publishing Process of This Article

Item

Count

Browse

1164

Download

1029

Sum=2193

Apr 16, 2013 (publication date) through Apr 18, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Cases. Apr 16, 2013; 1(1): 41-43
Published online Apr 16, 2013. doi: 10.12998/wjcc.v1.i1.41

Table 1 Laboratory values, median (range)

	Firstpresentation	Before percutaneousliver biopsy
GGT (U/L)	641 (10-71)	283 (10-71)
Alkaline phosphatase (U/L)	181 (40-129)	131 (40-129)
ALT (U/L)	109 (10-41)	25 (10-41)
Bilirubin (mg/dL)	3.4 (0.1-1.1)	1.5 (0.1-1.1)
C-reactive protein (mg/dL)	54.3 (0.0-0.5)	9.4 (0.0-0.5)

GGT: Gamma-glutamyl transpeptidase; ALT: Alanine transaminase.

Citation: Claudi C, Henschel M, Vogel J, Schepke M, Biecker E. Fulminant sepsis after liver biopsy: A long forgotten complication? World J Clin Cases 2013; 1(1): 41-43
URL: https://www.wjgnet.com/2307-8960/full/v1/i1/41.htm
DOI: https://dx.doi.org/10.12998/wjcc.v1.i1.41